Cytokinetics sec filings

Author: zcks

August undefined, 2024

WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Our Vision. ... SEC Filings. Annual Report and Proxy. Analyst Coverage. Investor FAQ. IR/Media Contacts. Corporate Governance. Information Request. Email Alerts. WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining.

China Universal Asset Management Co. Ltd. Lowers Holdings in ...

WebUnder the Securities Exchange Act of 1934 (AMENDMENT NO. 1) CYTOKINETICS, INCORPORATED (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER … WebApr 12, 2024 · The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, CEO Robert I. Blum sold 12,500 shares of the stock in a transaction that ... mobily charge

CYTK SEC Filings - Cytokinetics, Inc. - Annual Report, Proxy …

WebFind the latest SEC Filings data for Cytokinetics, Incorporated Common Stock (CYTK) at Nasdaq.com. Cytokinetics, Incorporated Common Stock (CYTK) SEC Filings … WebFeb 17, 2024 · Cytokinetics Inc CIK: 1061983 Ticker: CYTK GET DIRECTION ON YOUR INVESTMENTS Integrate SEC filing data within your own apps using our API Sign up Key Features Various SEC filing data available including balance sheets, cash flows and more Central Index Key (CIK) and ticker conversions for looking up companies WebFind the latest SEC Filings data for Cytokinetics, Incorporated Common Stock (CYTK) at Nasdaq.com. mobily case study

Cytokinetics, Incorporated Common Stock (CYTK) SEC …

Allspring Global Investments Holdings LLC Has $8.88 Million Stock ...

WebPipeline - Cytokinetics A pipeline powered by passion pipeline Research Pre-Clinical Phase 1 Phase 2 Phase 3 CARDIAC MUSCLE Omecamtiv Mecarbil (Heart Failure) Aficamten (oHCM) Aficamten (nHCM) CK-136 (Heart Failure, other) CK-586 SKELETAL MUSCLE Reldesemtiv (ALS) Additional Skeletal Muscle Activators Other Muscle Biology … WebCytokinetics Inc. SEC filings breakout by MarketWatch. View the CYTK U.S. Securities and Exchange Commission reporting information. mobily catWebJan 9, 2024 · Filings & Forms All companies, foreign and domestic, are required to file registration statements, periodic reports, and other forms electronically through EDGAR. Anyone can access and download this information for free. Here you'll find links to a complete list of filings available through EDGAR and instructions for searching the … ink toner northampton ma

"" - Cytokinetics sec filings

Cytokinetics sec filings

Cytokinetics Announces Pricing of $450 Million Convertible

WebMar 31, 2024 · Latest SEC filings for Cytokinetics, Incorporated (CYTK). Latest SEC filings for Cytokinetics, Incorporated (CYTK) Seeking Alpha Seeking Alpha - Go to … WebFeb 25, 2024 · Cytokinetics Inc (CYTK) SEC Filing 10-K Annual Report for the fiscal year ending Friday, December 31, 2024 Earnings Press Release 10-K Annual Report 10-K …

Did you know?

WebApr 10, 2024 · Cytokinetics assumes no obligation to update its forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release. WebApr 12, 2024 · Oregon Public Employees Retirement Fund lifted its position in shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Get Rating) by 1.0% in the 4th quarter, …

WebMar 27, 2024 · INVESTORS & MEDIA SEC FILINGS SEC Filing Keyword Search Group Filing year Items per page 10 1 2 3 4 5 6 7 8 9 … Next › Last » Displaying 1 - 10 of 1876 results Mar 07 2024 10:35 am EST Data Provided by Refinitiv. Minimum 15 minutes delayed. STOCK CHART WebItem 1.01 Entry into a Material Definitive Agreement. On February 1, 2024, Cytokinetics, Incorporated ("Cytokinetics") entered into a Royalty Purchase Agreement (the "Royalty Agreement") with RPI Finance Trust ("RPI"), an entity related to Royalty Pharma.

WebJan 8, 2024 · According to the 10-Q SEC Filing, Cytokinetics had cash, cash equivalents and investments of $668.9 million as of September 30, 2024. A big reason for the cash on hand was because of an offering ... WebApr 10, 2024 · Cytokinetics To Participate In The 22nd Annual Needham Virtual Healthcare Conference. SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK ...

WebFeb 22, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. …

WebApr 4, 2024 · Pinnacle Associates Ltd. owned approximately 0.30% of Cytokinetics worth $11,556,000 as of its most recent SEC filing. Want Diversified Upside in Biotechnology? … ink toner seller companies in alaskaWebNov 4, 2024 · SEC Filings Cytokinetics Inc (CYTK) 10-Q Quarterly Report Fri Nov 04 2024 SEC Filings CYTK Valuations Intrinsic Value Financial Stability Financial Ratios Insider … mobily balance transfer pakistanWeb15 hours ago · Related SEC Filings. CYTOKINETICS INC: Malik Fady Ibraham (EVP Research & Development) Sells 4,000 @ Avg Price: $34.21 (Form4) 36 minutes ago. CYTOKINETICS INC (FormARS) 6 days ago. CYTOKINETICS ... mobily caseWebMar 13, 2024 · Thornburg Investment Management Inc. acquired a new stake in shares of Cytokinetics, Incorporated (NASDAQ:CYTK - Get Rating) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 74,198 shares of the biop mobily chebWebMar 3, 2024 · Fri., March 3, 2024 MarketBeat Logos Global Management LP cut its holdings in shares of Cytokinetics, Incorporated ( NASDAQ:CYTK - Get Rating) by 2.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). inktopaper.comWebMar 27, 2024 · empowering muscle empowering lives. Cytokinetics is committed to our mission of developing potential medicines that may improve the healthspan of people living with cardiovascular and … ink toner refill kingswayWebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. ... SEC Filings. Document Details. Form. 144 Filing Date. Apr 13, 2024 ... ink toner refill vancouver bc